JNJ vs TLS · P/E 17, rev $49.37B vs rev $95.5M
Johnson & Johnson (JNJ) versus Telos Corp (TLS) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Telos Corp (TLS) is a software - infrastructure company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported TLS revenue for 2026-06-30 was $95.5M. Net income was $2.7M. TLS currently screens at market cap $327.0M.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. TLS currently screens at market cap $327.0M.
Not investment advice. Open the JNJ and TLS stock pages for the full models.
Not investment advice.